R K Swamy Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
RKSWAMY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
R K Swamy Limited has filed a quarterly compliance statement for the quarter ended December 31, 2025, confirming there is no deviation or variation in the use of IPO proceeds from the objects disclosed in its March 2024 prospectus. The IPO had raised Rs. 4,235.60 million in total (Rs. 1,730 million fresh issue + Rs. 2,505.60 million offer for sale). Out of Rs. 1,563.25 million allocated from fresh issue proceeds, the company has utilised Rs. 1,047.96 million so far. Working capital funding (Rs. 540 million) and general corporate purposes (Rs. 362.62 million) have been fully utilised earlier. IT infrastructure investment has seen Rs. 69.94 million utilised this quarter (partially utilised), and setting up new CEC and CATI has seen Rs. 75.40 million (partially utilised). The DVCP Studio allocation of Rs. 109.85 million recorded no utilisation during the quarter. CRISIL Ratings is the monitoring agency, and the Audit Committee and Board reviewed the statement on February 12-13, 2026.
This is a routine regulatory compliance filing with no negative signal, as the company has confirmed full alignment between actual IPO fund usage and stated objects. Investors should note that around Rs. 515 million of allocated fresh-issue proceeds are still pending deployment, including the DVCP Studio capex which has not moved this quarter, suggesting ongoing but slower-than-originally-planned execution on some objects.